Calliditas Therapeutics AB (publ) (CALT) Institutional Ownership $40.00 0.00 (0.00%) As of 01/16/2025 Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Calliditas Therapeutics AB (publ) (NASDAQ:CALT)CurrentInstitutional OwnershipPercentage2.83%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$669.91KNumber ofInstitutional Sellers(last 12 months)0 Get CALT Insider Trade Alerts Want to know when executives and insiders are buying or selling Calliditas Therapeutics AB (publ) stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CALT Institutional Buying and Selling by Quarter Calliditas Therapeutics AB (publ) Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/4/2024Crossmark Global Holdings Inc.16,117$655K0.0%N/A0.054% 2/13/2024Optiver Holding B.V.980$25K0.0%N/A0.003% 5/15/2023Ironwood Investment Management LLC27,795$666K0.4%+5.6%0.093% 5/11/2023Optiver Holding B.V.5,029$120K0.0%-54.9%0.017% 2/10/2023Optiver Holding B.V.11,141$195K0.0%-11.8%0.037% 2/9/2023HBK Sorce Advisory LLC90,000$104K0.0%+100.0%0.302% 1/31/2023Ironwood Investment Management LLC26,309$447K0.3%-8.5%0.088% 11/14/2022Optiver Holding B.V.12,625$191K0.0%+1,304.3%0.043% 11/14/2022HBK Sorce Advisory LLC45,000$50K0.0%N/A0.152% 5/10/2022Ironwood Investment Management LLC28,762$551K0.3%+5.5%0.110% 2/10/2022Ironwood Investment Management LLC27,267$675K0.3%-2.0%0.104% 11/12/2021Ironwood Investment Management LLC27,836$602K0.3%+75.2%0.106% 8/27/2021Endurant Capital Management LP144,393$4.25M1.2%+1.5%0.552% 8/12/2021Advisory Services Network LLC3,369$99K0.0%N/A0.013% 8/11/2021Deutsche Bank AG71,531$2.11M0.0%+1.8%0.286% 7/31/2021NEXT Financial Group Inc4,458$131K0.0%N/A0.018% 5/19/2021Hillhouse Capital Advisors LTD.944,716$26.10M0.3%-9.8%3.783% 5/18/2021Millennium Management LLC15,570$430K0.0%-24.0%0.062% 5/18/2021Tudor Investment Corp Et Al13,782$380K0.0%N/A0.055% 5/18/2021Citadel Advisors LLC9,571$264K0.0%N/A0.038% 5/17/2021Endurant Capital Management LP142,323$3.92M1.0%N/A0.570% 2/17/2021Jane Street Group LLC7,557$256K0.0%-26.5%0.032% 2/13/2021Hillhouse Capital Advisors LTD.1,047,687$35.61M0.3%+199.3%4.371% (Data available from 1/1/2016 forward) CALT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CALT shares? During the previous two years, the following institutional investors and hedge funds held shares of Calliditas Therapeutics AB (publ) shares: Ironwood Investment Management LLC ($666K), Crossmark Global Holdings Inc. ($655K), and HBK Sorce Advisory LLC ($104K), Optiver Holding B.V. ($25K).Learn more on CALT's institutional investors. What percentage of Calliditas Therapeutics AB (publ) stock is owned by institutional investors? 2.83% of Calliditas Therapeutics AB (publ) stock is owned by institutional investors. Learn more on CALT's institutional investor holdings. Which institutional investors have been buying Calliditas Therapeutics AB (publ) stock? The following institutional investors have purchased Calliditas Therapeutics AB (publ) stock in the last 24 months: HBK Sorce Advisory LLC ($45K), Crossmark Global Holdings Inc. ($16.12K), Ironwood Investment Management LLC ($1.49K), and Optiver Holding B.V. ($980.00). How much institutional buying is happening at Calliditas Therapeutics AB (publ)? Institutional investors have bought a total of 63,583 shares in the last 24 months. This purchase volume represents approximately $1.47M in transactions. Which Calliditas Therapeutics AB (publ) major shareholders have been selling company stock? The following institutional investors have sold Calliditas Therapeutics AB (publ) stock in the last 24 months: Optiver Holding B.V. ($7.60K), and Ironwood Investment Management LLC ($2.43K). How much institutional selling is happening at Calliditas Therapeutics AB (publ)? Institutional investors have sold a total of 10,029 shares in the last 24 months. This volume of shares sold represents approximately $213.09K in transactions. Related Companies Viking Therapeutics Major Shareholders Axsome Therapeutics Major Shareholders Krystal Biotech Major Shareholders TG Therapeutics Major Shareholders Organon & Co. Major Shareholders Scholar Rock Major Shareholders Alvotech Major Shareholders Ultragenyx Pharmaceutical Major Shareholders ADMA Biologics Major Shareholders Biohaven Major Shareholders This page (NASDAQ:CALT) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calliditas Therapeutics AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Calliditas Therapeutics AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
